Picture of Biomerieux SA logo

BIM Biomerieux SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Brief: Biomerieux FY Sales Expected To Grow Organically By 8% to 10%

Sept 5 (Reuters) - Biomerieux SA  BIOX.PA :
    * H1 OPERATING INCOME EUR 288 MILLION VERSUS EUR 208 MILLION
    * H1 NET INCOME GROUP SHARE EUR 215 MILLION VERSUS EUR 162
MILLION
    * H1 ORGANIC SALES EUR 1.90 BILLION
    * 2024 FULL YEAR GUIDANCE REVISED UPWARD
    * 2024 FULL YEAR GUIDANCE: SALES EXPECTED TO GROW
ORGANICALLY BY
+8% TO +10%
    * 2024 FULL YEAR GUIDANCE:  CEBIT TO GROW BY +12% TO +17%
ORGANICALLY
    * 2024 FULL YEAR GUIDANCE: FULL YEAR EXCHANGE RATES IMPACT
IS
EXPECTED TO BE  NEGATIVE IN THE RANGE OF -€70M
    * CONSOLIDATED NET DEBT CAME TO EUR 286 MILLION AS OF JUNE
30,
2024

Further company coverage:  BIOX.PA 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))

Recent news on Biomerieux SA

See all news